Literature DB >> 24215414

Prevention of asthma: where are we in the 21st century?

Phaedra Propp1, Allan Becker.   

Abstract

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment interactions. There is consensus that a 'window of opportunity' exists during pregnancy and early in life when environmental factors may influence its development. We review multiple environmental, biologic and sociologic factors that may be important in the development of asthma. Meta-analyses of studies have demonstrated that multifaceted interventions are required in order to develop asthma prevention. Multifaceted allergen reduction studies have shown clinical benefits. Asthma represents a dysfunctional interaction with our genes and the environment to which they are exposed, especially in fetal and early infant life. The increasing prevalence of asthma also may be an indication of increased population risk for the development of other chronic non-communicable autoimmune diseases. This review will focus on the factors which may be important in the primary prevention of asthma. Better understanding of the complex gene-environment interactions involved in the development of asthma will provide insight into personalized interventions for asthma prevention.

Entities:  

Mesh:

Year:  2013        PMID: 24215414     DOI: 10.1586/1744666X.2013.858601

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  5 in total

Review 1.  Developing Primary Intervention Strategies to Prevent Allergic Disease.

Authors:  Kristina Rueter; Aveni Haynes; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

2.  Prevalence of wheezing and atopic diseases in Austrian schoolchildren in conjunction with urban, rural or farm residence.

Authors:  Elisabeth Horak; Bernhard Morass; Hanno Ulmer; Jon Genuneit; Charlotte Braun-Fahrländer; Erika von Mutius
Journal:  Wien Klin Wochenschr       Date:  2014-07-22       Impact factor: 1.704

3.  Pharmacokinetics of tralokinumab in adolescents with asthma: implications for future dosing.

Authors:  Paul G Baverel; Meena Jain; Iwona Stelmach; Dewei She; Balaji Agoram; Sara Sandbach; Edward Piper; Piotr Kuna
Journal:  Br J Clin Pharmacol       Date:  2015-10-01       Impact factor: 4.335

4.  Early life environmental predictors of asthma age-of-onset.

Authors:  Olivia R Ferry; David L Duffy; Manuel A R Ferreira
Journal:  Immun Inflamm Dis       Date:  2014-07-26

5.  Syndecan-1 Amplifies Ovalbumin-Induced Airway Remodeling by Strengthening TGFβ1/Smad3 Action.

Authors:  Dong Zhang; Xin-Rui Qiao; Wen-Jing Cui; Jin-Tao Zhang; Yun Pan; Xiao-Fei Liu; Liang Dong
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.